These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11930941)

  • 1. Local fibrinolytic therapy with urokinase for peritoneal dialysis catheter obstruction in children.
    Stadermann MB; Rusthoven E; van de Kar NC; Hendriksen A; Monnens LA; Schröder CH
    Perit Dial Int; 2002; 22(1):84-6. PubMed ID: 11930941
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator for occluded peritoneal dialysis catheter.
    Sakarcan A; Stallworth JR
    Pediatr Nephrol; 2002 Mar; 17(3):155-6. PubMed ID: 11956850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator for blocked peritoneal dialysis catheters.
    Krishnan RG; Moghal NE
    Pediatr Nephrol; 2006 Feb; 21(2):300. PubMed ID: 16252099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
    Eyrich H; Walton T; Macon EJ; Howe A
    Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic treatment of portal vein thrombosis after umbilical catheterization using systemic urokinase.
    Distefano G; Rodono A; Cilauro S; Saporito A; Pennisi F; Smilari P; Romeo MG; Amato M
    Pediatr Int; 2000 Feb; 42(1):82-4. PubMed ID: 10703242
    [No Abstract]   [Full Text] [Related]  

  • 6. Endoluminal brushing of blocked indwelling haemodialysis catheters.
    Bel'eed K; Kumar A; Asin M; Sellars L
    Nephrol Dial Transplant; 1999 Jan; 14(1):241. PubMed ID: 10052522
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of primary omentectomy on longevity of peritoneal dialysis catheters in children.
    Ladd AP; Breckler FD; Novotny NM
    Am J Surg; 2011 Mar; 201(3):401-4; discussion 404-5. PubMed ID: 21367387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clotted central vein catheter for haemodialysis.
    Twardowski ZJ
    Nephrol Dial Transplant; 1998 Sep; 13(9):2203-6. PubMed ID: 9761497
    [No Abstract]   [Full Text] [Related]  

  • 9. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters.
    Jones GR; Konsler GK; Dunaway RP
    Am J Infect Control; 1996 Jun; 24(3):160-6. PubMed ID: 8806991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of intrapleural urokinase in the treatment of childhood empyema.
    Thomson AH; Hull J; Kumar MR; Wallis C; Balfour Lynn IM
    Thorax; 2002 Apr; 57(4):343-7. PubMed ID: 11923554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
    Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
    Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis.
    Savage SA; Young G; Reaman GH
    Med Pediatr Oncol; 2000 Mar; 34(3):215-7. PubMed ID: 10696131
    [No Abstract]   [Full Text] [Related]  

  • 13. Another peritoneal dialysis catheter encapsulated in peritoneal tissue.
    Prischl FC; Knoll F; Kramar R
    Perit Dial Int; 2009; 29(1):119-20. PubMed ID: 19164264
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
    Czyrski J
    Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for morbidity and mortality in pediatric patients with peritoneal dialysis catheters.
    Phan J; Stanford S; Zaritsky JJ; DeUgarte DA
    J Pediatr Surg; 2013 Jan; 48(1):197-202. PubMed ID: 23331815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use and complications of three peritoneal dialysis catheter designs. A retrospective analysis.
    Flanigan MJ; Ngheim DD; Schulak JA; Ullrich GE; Freeman RM
    ASAIO Trans; 1987; 33(1):33-8. PubMed ID: 3828160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis.
    Atkinson JB; Chamberlin K; Boody BA
    J Pediatr Surg; 1998 May; 33(5):714-6. PubMed ID: 9607475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unblocking peritoneal dialysis catheters with a combination of urokinase and Fogarty catheter manipulation.
    Stringel G; Olsen S; Cascio C
    Adv Perit Dial; 1995; 11():200-1. PubMed ID: 8534705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy with urokinase.
    Majors DS
    ANNA J; 1996 Dec; 23(6):627-9. PubMed ID: 9069793
    [No Abstract]   [Full Text] [Related]  

  • 20. Regarding "The safety, efficacy and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions".
    Manfredini R; Boari B; Gallerani M; Portaluppi F; Mehta RH
    J Vasc Surg; 2003 Aug; 38(2):411-2. PubMed ID: 12894792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.